• Close Shade
  • Pin Shade
  • Expand Shade
Headline: Press release Oncology Venture acquires full ownership of its PARP inhibitor (2X-121) program
Location: Hoersholm, Denmark
Post Date: Jul 13, 2020 8:32 AM
TAG ID: pznewsml314759
DocID: 202007131000367362-en.newsml
Word Count: approx. 1155 words
 
Press release Oncology Venture acquires full ownership of its PARP inhibitor (2X-121) programPress release Oncology Venture acquires full ownership of its PARP inhibitor (2X-121) programHoersholm, Denmark (13 July 2020) – Oncology Venture A
 
Please login to download this Story